(Q33707377)

28 July 2017

1 reference

title

Glycemic control and cardiovascular disease in type 2 diabetes: a review (English)

1 reference

28 July 2017

1 reference

cardiovascular disease

1 reference

Wild SH

1

1 reference

28 July 2017

Dunn CJ

series ordinal

2

1 reference

28 July 2017

McKeigue PM

series ordinal

3

1 reference

28 July 2017

Comte S

series ordinal

4

1 reference

28 July 2017

language of work or name

1 reference

1 May 1999

1 reference

Diabetes - Metabolism: Research and Reviews

28 July 2017

1 reference

28 July 2017

15

1 reference

28 July 2017

3

1 reference

28 July 2017

197-204

1 reference

Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?

28 July 2017

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

Diabetes mellitus and macrovascular complications. An epidemiological perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

Undiagnosed NIDDM: clinical and public health issues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

The role of insulin resistance and hyperinsulinemia in coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

Do non-insulin-dependent diabetes mellitus and cardiovascular disease share common antecedents?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

Lipoprotein glycation and its metabolic consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

Epidemiological evidence for the association of hyperglycaemia and atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VII. Mortality and selected nonfatal events with insulin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

Effects of insulin on cholesterol synthesis in type II diabetes patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

Metformin improves blood lipid pattern in nondiabetic patients with coronary heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

The effects of metformin on cardiovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

Metformin for obese, insulin-treated diabetic patients: improvement in glycaemic control and reduction of metabolic risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

Influence of risk factors on peripheral and cerebrovascular disease in men with coronary artery disease, low high-density lipoprotein cholesterol levels, and desirable low-density lipoprotein cholesterol levels. HIT Investigators. Department of Vete

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

Interaction between cigarette smoking and diabetes mellitus in the prediction of death attributed to cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

Does glycemic control of type II diabetes suffice to control diabetic dyslipidemia? A community perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

Antiplatelet therapy for thromboprophylaxis: the need for careful consideration of the evidence from randomised trials. Antiplatelet Trialists' Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

Development of macrovascular diseases in NIDDM patients in northern Taiwan. A 4-yr follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

Comparative approaches to risk reduction of coronary heart disease in Tecumseh non-insulin-dependent diabetic population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

Starting insulin therapy in patients with type 2 diabetes: effectiveness, complications, and resource utilization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

Non-insulin-dependent diabetes and its metabolic control are important predictors of stroke in elderly subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

Long-term glycemic control relates to mortality in type II diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

Predictors of stroke in middle-aged patients with non-insulin-dependent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

Predictors of 10-year macrovascular and overall mortality in patients with NIDDM: the Munich General Practitioner Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

Macrovascular disease and hyperglycaemia: 10-year survival analysis in Type 2 diabetes mellitus: the Belfast Diet Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

Mortality in diabetic patients participating in an ophthalmological control and screening programme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

The feasibility of intensive insulin management in non-insulin-dependent diabetes mellitus. Implications of the Veterans Affairs Cooperative Study on Glycemic Control and Complications in NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

Is there a glycemic threshold for mortality risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry. Honolulu Heart Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

Comparisons of studies on diabetic complications hampered by differences in GHb measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

NIDDM and its metabolic control predict coronary heart disease in elderly subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

Low incidence of fatal coronary heart disease in Pima Indians despite high prevalence of non-insulin-dependent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

The UK Prospective Diabetes Study. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

The pharmacological treatment of hyperglycemia in NIDDM. American Diabetes Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

The effect of diabetic control on very low-density lipoprotein--triglyceride metabolism in patients with type II diabetes mellitus and marked hypertriglyceridemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

Diabetes and long-term risk of mortality from coronary and other causes in middle-aged Swedish men. A general population study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

The association of glycemia and cause-specific mortality in a diabetic population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

Albuminuria and Poor Glycemic Control Predict Mortality in NIDDM

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

Effect of intensive treatment of diabetes of the risk of death or renal failure in NIDDM and IDDM

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291520-7560%28199905%2F06%2915%3A3%3C197%3A%3AAID-DMRR28%3E3.0.CO%3B2-F

10.1002/(SICI)1520-7560(199905/06)15:3<197::AID-DMRR28>3.0.CO;2-F

21 January 2018

Identifiers

DOI

1 reference

28 July 2017

1 reference